Half year results 2020

Intelligent Ultrasound (AIM: MED), the artificial intelligence (AI) based ultrasound software and simulation company, announces its unaudited half year results to 30 June 2020. Despite the global impact of Covid19, the Company reduced its EBITDA¹ loss to £1.2m (H1 2019: loss of £1.3m) on a reduced revenue of £2.5m (H1 2019: £3.1m) and continued to successfully progress the development of four AI software products.  

MED – interims RNS (06.08.20)